Alligator Bioscience has completed an oversubscribed preferential rights issue of approximately SEK 257 million.

Alligator Bioscience is a biotechnology company in the clinical phase that develops antibody-based pharmaceuticals for cancer treatment. The company's head office is located at Medicon Village in Lund, Sweden.

DNB Markets and Redeye acted as Joint Bookrunners in the transaction while Baker McKenzie acted as legal advisor to the Joint Bookrunners with a Capital Markets team consisting of Joakim Falkner, Johanna Flink and Nanna Trulsson.

Explore Our Newsroom